Loading…

Oral recurrent human herpes virus infection and bone marrow transplantation survival

Objective: This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation. Study Design: Fifty-two consecut...

Full description

Saved in:
Bibliographic Details
Published in:Oral surgery, oral medicine, oral pathology, oral radiology and endodontics oral medicine, oral pathology, oral radiology and endodontics, 2001-05, Vol.91 (5), p.552-556
Main Authors: Gomez, Ricardo Santiago, Carneiro, Marcelo Antunes, Souza, Leandro Napier, Victória, Júnia Maria Netto, de Azevedo, Wellington Moraes, De Marco, Luiz, Kalapothakis, Evanguedes
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693
cites cdi_FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693
container_end_page 556
container_issue 5
container_start_page 552
container_title Oral surgery, oral medicine, oral pathology, oral radiology and endodontics
container_volume 91
creator Gomez, Ricardo Santiago
Carneiro, Marcelo Antunes
Souza, Leandro Napier
Victória, Júnia Maria Netto
de Azevedo, Wellington Moraes
De Marco, Luiz
Kalapothakis, Evanguedes
description Objective: This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation. Study Design: Fifty-two consecutive patients who underwent BMT were included in the study. The time of death after BMT was displayed, by means of the Kaplan-Meier method, for the following parameters: age and gender of the patient, donor gender, primary disease, stem cells, conditioning regimen, platelet number after day 100, acute and chronic graft-versus-host disease, oral recurrent HHV-1 infection post-BMT, oral lichenoid lesions of graft-versus-host disease, graft-versus-host disease at the salivary glands, parenteral nutrition, and oral mucositis. The data were initially analyzed by means of the log-rank test and then included in the Cox proportional hazards model. Results: The multivariate analysis demonstrated a significance of 5% for only the platelet numbers and oral recurrent HHV-1 infection. Conclusion: The present study provides evidence that platelet numbers below 100,000 cells/mm3 after day 100 and oral recurrent HHV-1 infection are independent negative prognostic variables in BMT patients’ 24-month survival rates. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:552-6)
doi_str_mv 10.1067/moe.2001.112568
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70841709</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1079210401742588</els_id><sourcerecordid>70841709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMofp-9SUDw1t1J0zTNUcQvWPCi4C2k6ZSNtOmatCv-e7PuoidPMzDPvMw8hFwwmDEo5bwfcJYDsBljuSirPXLMRF5lXIm3_dSDVFnOoDgiJzG-A0DJlTokR4zxopS8OCYvz8F0NKCdQkA_0uXUG0-XGFYY6dqFKVLnW7SjGzw1vqH14JH2JoThk47B-LjqjB_NzzxOYe3WpjsjB63pIp7v6il5vb97uX3MFs8PT7c3i8xyycasllJinZeFwlbmyFthhTDQ1GXLoUAGyOpKyEqItq4sB1MYA1wwxUtpsVT8lFxvc1dh-Jgwjrp30WKXLsJhilpCVTAJG3C-BW0YYgzY6lVw6YkvzUBvROokUm9E6q3ItHG5i57qHps_fmcuAVc7wERrujapsC7-cqoSDDYxakth0rB2GHS0Dr3FxiXno24G9-8J3_pAj4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70841709</pqid></control><display><type>article</type><title>Oral recurrent human herpes virus infection and bone marrow transplantation survival</title><source>Elsevier</source><creator>Gomez, Ricardo Santiago ; Carneiro, Marcelo Antunes ; Souza, Leandro Napier ; Victória, Júnia Maria Netto ; de Azevedo, Wellington Moraes ; De Marco, Luiz ; Kalapothakis, Evanguedes</creator><creatorcontrib>Gomez, Ricardo Santiago ; Carneiro, Marcelo Antunes ; Souza, Leandro Napier ; Victória, Júnia Maria Netto ; de Azevedo, Wellington Moraes ; De Marco, Luiz ; Kalapothakis, Evanguedes</creatorcontrib><description>Objective: This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation. Study Design: Fifty-two consecutive patients who underwent BMT were included in the study. The time of death after BMT was displayed, by means of the Kaplan-Meier method, for the following parameters: age and gender of the patient, donor gender, primary disease, stem cells, conditioning regimen, platelet number after day 100, acute and chronic graft-versus-host disease, oral recurrent HHV-1 infection post-BMT, oral lichenoid lesions of graft-versus-host disease, graft-versus-host disease at the salivary glands, parenteral nutrition, and oral mucositis. The data were initially analyzed by means of the log-rank test and then included in the Cox proportional hazards model. Results: The multivariate analysis demonstrated a significance of 5% for only the platelet numbers and oral recurrent HHV-1 infection. Conclusion: The present study provides evidence that platelet numbers below 100,000 cells/mm3 after day 100 and oral recurrent HHV-1 infection are independent negative prognostic variables in BMT patients’ 24-month survival rates. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:552-6)</description><identifier>ISSN: 1079-2104</identifier><identifier>EISSN: 1528-395X</identifier><identifier>DOI: 10.1067/moe.2001.112568</identifier><identifier>PMID: 11346734</identifier><language>eng</language><publisher>St. Louis, MO: Mosby, Inc</publisher><subject>Acute Disease ; Acyclovir - therapeutic use ; Adolescent ; Adult ; Age Factors ; Anemia, Aplastic - therapy ; Antiviral Agents - therapeutic use ; Biological and medical sciences ; Bone Marrow Transplantation ; Chronic Disease ; Dentistry ; Female ; Graft vs Host Disease - etiology ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Leukemia - therapy ; Linear Models ; Lymphoma - therapy ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Platelet Count ; Prognosis ; Proportional Hazards Models ; Recurrence ; Salivary Gland Diseases - etiology ; Sex Factors ; Stomatitis - etiology ; Stomatitis, Herpetic - drug therapy ; Stomatitis, Herpetic - etiology ; Stomatitis, Herpetic - prevention &amp; control ; Survival Rate ; Tissue Donors ; Transplantation Conditioning ; Tropical medicine ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases</subject><ispartof>Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 2001-05, Vol.91 (5), p.552-556</ispartof><rights>2001 Mosby, Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693</citedby><cites>FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=985108$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11346734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gomez, Ricardo Santiago</creatorcontrib><creatorcontrib>Carneiro, Marcelo Antunes</creatorcontrib><creatorcontrib>Souza, Leandro Napier</creatorcontrib><creatorcontrib>Victória, Júnia Maria Netto</creatorcontrib><creatorcontrib>de Azevedo, Wellington Moraes</creatorcontrib><creatorcontrib>De Marco, Luiz</creatorcontrib><creatorcontrib>Kalapothakis, Evanguedes</creatorcontrib><title>Oral recurrent human herpes virus infection and bone marrow transplantation survival</title><title>Oral surgery, oral medicine, oral pathology, oral radiology and endodontics</title><addtitle>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</addtitle><description>Objective: This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation. Study Design: Fifty-two consecutive patients who underwent BMT were included in the study. The time of death after BMT was displayed, by means of the Kaplan-Meier method, for the following parameters: age and gender of the patient, donor gender, primary disease, stem cells, conditioning regimen, platelet number after day 100, acute and chronic graft-versus-host disease, oral recurrent HHV-1 infection post-BMT, oral lichenoid lesions of graft-versus-host disease, graft-versus-host disease at the salivary glands, parenteral nutrition, and oral mucositis. The data were initially analyzed by means of the log-rank test and then included in the Cox proportional hazards model. Results: The multivariate analysis demonstrated a significance of 5% for only the platelet numbers and oral recurrent HHV-1 infection. Conclusion: The present study provides evidence that platelet numbers below 100,000 cells/mm3 after day 100 and oral recurrent HHV-1 infection are independent negative prognostic variables in BMT patients’ 24-month survival rates. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:552-6)</description><subject>Acute Disease</subject><subject>Acyclovir - therapeutic use</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Anemia, Aplastic - therapy</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow Transplantation</subject><subject>Chronic Disease</subject><subject>Dentistry</subject><subject>Female</subject><subject>Graft vs Host Disease - etiology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Leukemia - therapy</subject><subject>Linear Models</subject><subject>Lymphoma - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Platelet Count</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Recurrence</subject><subject>Salivary Gland Diseases - etiology</subject><subject>Sex Factors</subject><subject>Stomatitis - etiology</subject><subject>Stomatitis, Herpetic - drug therapy</subject><subject>Stomatitis, Herpetic - etiology</subject><subject>Stomatitis, Herpetic - prevention &amp; control</subject><subject>Survival Rate</subject><subject>Tissue Donors</subject><subject>Transplantation Conditioning</subject><subject>Tropical medicine</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><issn>1079-2104</issn><issn>1528-395X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LxDAQhoMofp-9SUDw1t1J0zTNUcQvWPCi4C2k6ZSNtOmatCv-e7PuoidPMzDPvMw8hFwwmDEo5bwfcJYDsBljuSirPXLMRF5lXIm3_dSDVFnOoDgiJzG-A0DJlTokR4zxopS8OCYvz8F0NKCdQkA_0uXUG0-XGFYY6dqFKVLnW7SjGzw1vqH14JH2JoThk47B-LjqjB_NzzxOYe3WpjsjB63pIp7v6il5vb97uX3MFs8PT7c3i8xyycasllJinZeFwlbmyFthhTDQ1GXLoUAGyOpKyEqItq4sB1MYA1wwxUtpsVT8lFxvc1dh-Jgwjrp30WKXLsJhilpCVTAJG3C-BW0YYgzY6lVw6YkvzUBvROokUm9E6q3ItHG5i57qHps_fmcuAVc7wERrujapsC7-cqoSDDYxakth0rB2GHS0Dr3FxiXno24G9-8J3_pAj4A</recordid><startdate>20010501</startdate><enddate>20010501</enddate><creator>Gomez, Ricardo Santiago</creator><creator>Carneiro, Marcelo Antunes</creator><creator>Souza, Leandro Napier</creator><creator>Victória, Júnia Maria Netto</creator><creator>de Azevedo, Wellington Moraes</creator><creator>De Marco, Luiz</creator><creator>Kalapothakis, Evanguedes</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010501</creationdate><title>Oral recurrent human herpes virus infection and bone marrow transplantation survival</title><author>Gomez, Ricardo Santiago ; Carneiro, Marcelo Antunes ; Souza, Leandro Napier ; Victória, Júnia Maria Netto ; de Azevedo, Wellington Moraes ; De Marco, Luiz ; Kalapothakis, Evanguedes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acute Disease</topic><topic>Acyclovir - therapeutic use</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Anemia, Aplastic - therapy</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow Transplantation</topic><topic>Chronic Disease</topic><topic>Dentistry</topic><topic>Female</topic><topic>Graft vs Host Disease - etiology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Leukemia - therapy</topic><topic>Linear Models</topic><topic>Lymphoma - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Platelet Count</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Recurrence</topic><topic>Salivary Gland Diseases - etiology</topic><topic>Sex Factors</topic><topic>Stomatitis - etiology</topic><topic>Stomatitis, Herpetic - drug therapy</topic><topic>Stomatitis, Herpetic - etiology</topic><topic>Stomatitis, Herpetic - prevention &amp; control</topic><topic>Survival Rate</topic><topic>Tissue Donors</topic><topic>Transplantation Conditioning</topic><topic>Tropical medicine</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gomez, Ricardo Santiago</creatorcontrib><creatorcontrib>Carneiro, Marcelo Antunes</creatorcontrib><creatorcontrib>Souza, Leandro Napier</creatorcontrib><creatorcontrib>Victória, Júnia Maria Netto</creatorcontrib><creatorcontrib>de Azevedo, Wellington Moraes</creatorcontrib><creatorcontrib>De Marco, Luiz</creatorcontrib><creatorcontrib>Kalapothakis, Evanguedes</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral surgery, oral medicine, oral pathology, oral radiology and endodontics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gomez, Ricardo Santiago</au><au>Carneiro, Marcelo Antunes</au><au>Souza, Leandro Napier</au><au>Victória, Júnia Maria Netto</au><au>de Azevedo, Wellington Moraes</au><au>De Marco, Luiz</au><au>Kalapothakis, Evanguedes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral recurrent human herpes virus infection and bone marrow transplantation survival</atitle><jtitle>Oral surgery, oral medicine, oral pathology, oral radiology and endodontics</jtitle><addtitle>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</addtitle><date>2001-05-01</date><risdate>2001</risdate><volume>91</volume><issue>5</issue><spage>552</spage><epage>556</epage><pages>552-556</pages><issn>1079-2104</issn><eissn>1528-395X</eissn><abstract>Objective: This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation. Study Design: Fifty-two consecutive patients who underwent BMT were included in the study. The time of death after BMT was displayed, by means of the Kaplan-Meier method, for the following parameters: age and gender of the patient, donor gender, primary disease, stem cells, conditioning regimen, platelet number after day 100, acute and chronic graft-versus-host disease, oral recurrent HHV-1 infection post-BMT, oral lichenoid lesions of graft-versus-host disease, graft-versus-host disease at the salivary glands, parenteral nutrition, and oral mucositis. The data were initially analyzed by means of the log-rank test and then included in the Cox proportional hazards model. Results: The multivariate analysis demonstrated a significance of 5% for only the platelet numbers and oral recurrent HHV-1 infection. Conclusion: The present study provides evidence that platelet numbers below 100,000 cells/mm3 after day 100 and oral recurrent HHV-1 infection are independent negative prognostic variables in BMT patients’ 24-month survival rates. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:552-6)</abstract><cop>St. Louis, MO</cop><pub>Mosby, Inc</pub><pmid>11346734</pmid><doi>10.1067/moe.2001.112568</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-2104
ispartof Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 2001-05, Vol.91 (5), p.552-556
issn 1079-2104
1528-395X
language eng
recordid cdi_proquest_miscellaneous_70841709
source Elsevier
subjects Acute Disease
Acyclovir - therapeutic use
Adolescent
Adult
Age Factors
Anemia, Aplastic - therapy
Antiviral Agents - therapeutic use
Biological and medical sciences
Bone Marrow Transplantation
Chronic Disease
Dentistry
Female
Graft vs Host Disease - etiology
Human viral diseases
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infectious diseases
Leukemia - therapy
Linear Models
Lymphoma - therapy
Male
Medical sciences
Middle Aged
Multivariate Analysis
Platelet Count
Prognosis
Proportional Hazards Models
Recurrence
Salivary Gland Diseases - etiology
Sex Factors
Stomatitis - etiology
Stomatitis, Herpetic - drug therapy
Stomatitis, Herpetic - etiology
Stomatitis, Herpetic - prevention & control
Survival Rate
Tissue Donors
Transplantation Conditioning
Tropical medicine
Viral diseases
Viral diseases of the respiratory system and ent viral diseases
title Oral recurrent human herpes virus infection and bone marrow transplantation survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A16%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20recurrent%20human%20herpes%20virus%20infection%20and%20bone%20marrow%20transplantation%20survival&rft.jtitle=Oral%20surgery,%20oral%20medicine,%20oral%20pathology,%20oral%20radiology%20and%20endodontics&rft.au=Gomez,%20Ricardo%20Santiago&rft.date=2001-05-01&rft.volume=91&rft.issue=5&rft.spage=552&rft.epage=556&rft.pages=552-556&rft.issn=1079-2104&rft.eissn=1528-395X&rft_id=info:doi/10.1067/moe.2001.112568&rft_dat=%3Cproquest_cross%3E70841709%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-b777eb2649ef72e3f5c55a0db6f304e10e1b857855fb8c30a4aa03519367ce693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70841709&rft_id=info:pmid/11346734&rfr_iscdi=true